A Relative Bioavailability Study of 200mg/5 mL Azithromycin Oral Suspension Under Non-Fasting Conditions
PHASE1CompletedINTERVENTIONAL
Enrollment
80
Participants
Timeline
Start Date
October 31, 2005
Primary Completion Date
November 30, 2005
Study Completion Date
November 30, 2005
Conditions
Healthy
Interventions
DRUG
Azithromycin
Oral Suspension
DRUG
Zithromax®
Oral Suspension
Trial Locations (1)
58104
PRACS Institute Ltd., Fargo
All Listed Sponsors
lead
Teva Pharmaceuticals USA
INDUSTRY
NCT00830336 - A Relative Bioavailability Study of 200mg/5 mL Azithromycin Oral Suspension Under Non-Fasting Conditions | Biotech Hunter | Biotech Hunter